Melanoma
Also known as: Malignant Melanoma, Cutaneous Melanoma
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. Although it accounts for only about 1% of skin cancers, melanoma causes the majority of skin cancer deaths due to its tendency to spread to other parts of the body. Early detection and surgical removal dramatically improve survival rates.
Last updated November 10, 2026
Understanding Melanoma
Melanoma is a cancer of melanocytes, the pigment cells of the skin, and although it makes up only about 1 percent of skin cancers it causes most skin cancer deaths. The American Cancer Society estimates roughly 105,000 new invasive melanomas and about 8,400 deaths in the United States in 2025, with a lifetime risk of about 1 in 33 for white Americans, 1 in 200 for Hispanic Americans and 1 in 1,000 for Black Americans. The median age at diagnosis is 66, yet it is one of the most common cancers in adults under 30, and before age 50 it is more common in women. Incidence rose for four decades and is now flattening in younger adults as tanning habits change. The reason this page exists is that outcomes depend overwhelmingly on when it is found: five-year relative survival is 99 percent when the tumor is still localized, about 75 percent once lymph nodes are involved and about 35 percent after distant spread.
Most melanomas carry the mutational fingerprint of ultraviolet damage, the C-to-T changes that UV leaves in DNA, layered on top of a driver mutation: BRAF V600 in about half, NRAS in a quarter and NF1 in about 15 percent. Contrary to what most people assume, roughly 70 percent arise on normal-looking skin rather than from an existing mole. The commonest type, superficial spreading melanoma, grows sideways within the top layer of skin for months to years before it starts growing down, and that radial phase is the window in which it is almost always curable. Nodular melanoma, about 15 percent of cases, skips the sideways phase, grows in weeks, and often fails the ABCDE rule because it is symmetrical, uniformly colored and sometimes pink or skin-colored. Once a melanoma invades, its depth in millimeters (Breslow thickness), surface ulceration and mitotic rate predict the chance it has seeded the lymphatics; the first draining node, the sentinel node, is where spread shows up first.
Care follows the American Academy of Dermatology 2019 guideline and the NCCN pathway. Dermoscopy improves accuracy over naked-eye inspection, and a suspicious lesion is removed whole with a 1 to 3 mm rim for pathology, never partially shaved or lasered. The definitive wide excision margin depends on thickness: 0.5 to 1 cm for melanoma in situ, 1 cm up to 1 mm, 1 to 2 cm for 1 to 2 mm and 2 cm beyond that. Sentinel node biopsy is offered from 0.8 mm thickness or with ulceration; since MSLT-II showed removing the remaining nodes adds no survival benefit, a positive node now leads to ultrasound surveillance plus a year of adjuvant pembrolizumab or nivolumab, which cut stage III recurrence by about 40 percent in trials. For advanced disease, CheckMate 067 reported 10-year survival of 43 percent with nivolumab plus ipilimumab, 37 percent with nivolumab alone and 19 percent with ipilimumab alone, and the 2024 NADINA trial showed immunotherapy before surgery in stage III nearly halved early relapse. BRAF-targeted drugs act fast, but immunotherapy first gives more durable benefit (DREAMseq).
No supplement, herb, diet or topical product treats melanoma. What the evidence supports is protection. In the Nambour trial, 1,621 Australian adults randomized to daily sunscreen for 4.5 years had half as many melanomas over the next decade as discretionary users. Nicotinamide 500 mg twice daily cut new basal and squamous cell cancers by 23 percent in the 386-patient ONTRAC trial but had no effect on melanoma, so it suits sun-damaged people who also get keratinocyte cancers and is not a melanoma drug. Low vitamin D at diagnosis correlates with thicker tumors, yet the 25,871-person VITAL trial found no reduction in melanoma from 2,000 IU daily, so correct a low level and skip megadoses. Some products do harm: in SU.VI.MAX, women taking an antioxidant combination for 7 years had about four times the melanoma incidence of placebo, selenium raised squamous cell cancer, probiotic users on anti-PD-1 therapy had lower response rates, and St John's wort lowers levels of BRAF and MEK inhibitors. Tell your oncologist about everything you take.
The most common mistake before diagnosis is waiting for a lesion to look like the textbook picture. Melanomas are frequently not black, not raised and not large; the better question is whether a spot is changing over weeks to months or looks different from every other mark on your body, the so-called ugly duckling, and whether it is new in someone over 40, when new moles are unusual. Any spot that fits should be seen within 2 to 4 weeks, not at the next annual check. The second mistake comes after diagnosis: delaying or replacing surgery with an alternative regimen while the tumor thickens. A 2018 analysis of the US National Cancer Database found that people who chose alternative medicine instead of conventional treatment for curable cancers were two and a half times more likely to die within about five years. Melanoma caught early is one of the most curable cancers there is; the window is real and it closes.
At a Glance
- Common symptoms
- New or changing mole with asymmetric shape, Mole with irregular or scalloped borders, Uneven color including shades of brown, black, red, or blue
- Main treatments
- Surgical excision with appropriate margins, Immunotherapy (pembrolizumab, nivolumab, ipilimumab), Targeted therapy for BRAF-mutant melanoma (dabrafenib, trametinib)
- Category
- Cancer · About 100,000 new cases diagnosed annually in the United States
- See a doctor if
- Any new mole or skin lesion that changes in size, shape, or color
Symptoms
Causes
- DNA damage to melanocytes, often from UV radiation
- Cumulative sun exposure and sunburn history
- Genetic mutations including BRAF, NRAS, and CDKN2A
- Use of tanning beds and artificial UV light
Risk Factors
- Fair skin, light hair, and light-colored eyes
- History of severe or blistering sunburns
- Family history of melanoma
- Large number of moles (more than 50)
- Weakened immune system
- Previous melanoma diagnosis
Diagnosis
- Full-body skin examination by a dermatologist
- Dermoscopy (magnified evaluation of skin lesions)
- Excisional biopsy of suspicious lesion with pathology review
- Sentinel lymph node biopsy for staging
- Imaging studies (CT, PET, MRI) for metastatic evaluation
Treatment
- Surgical excision with appropriate margins
- Immunotherapy (pembrolizumab, nivolumab, ipilimumab)
- Targeted therapy for BRAF-mutant melanoma (dabrafenib, trametinib)
- Radiation therapy for select cases
- Clinical trials for advanced disease
Natural remedies for melanoma: what the evidence says
Ranked by the strength of human evidence for melanoma specifically. These sit alongside medical care, not in place of it.
Nicotinamide (vitamin B3)
Moderate evidenceIn the phase 3 ONTRAC trial, 386 Australians who had already had at least two keratinocyte skin cancers took nicotinamide 500 mg twice daily or placebo for 12 months; new basal and squamous cell cancers fell by 23 percent and actinic keratoses by about 13 percent, with the benefit disappearing within 6 months of stopping. Melanoma numbers were tiny and did not differ, the trial excluded melanoma as an endpoint, and a 2023 trial in organ-transplant recipients found no significant benefit. This is Moderate evidence for preventing non-melanoma skin cancer in heavily sun-damaged people and no evidence for melanoma.
- Studied dose
- Nicotinamide (niacinamide) 500 mg twice daily with food, taken continuously; nicotinic acid (niacin) is a different form that causes flushing and does not substitute.
- Cautions
- Well tolerated at this dose; high doses of niacin, not nicotinamide, can raise liver enzymes and blood sugar. It is not a sunscreen substitute, has not been studied for melanoma prevention, and should be discussed with the oncologist if you are on active treatment.
Vitamin D
Preliminary evidenceIn 872 people with melanoma in Leeds, a lower serum 25-hydroxyvitamin D at diagnosis was associated with thicker tumors and worse relapse-free survival, and similar associations appear in other cohorts. Association is not causation, and the large VITAL trial (25,871 adults, 2,000 IU daily for a median 5.3 years) found no reduction in melanoma or in total cancer incidence, so vitamin D does not prevent melanoma. Correcting a documented deficiency is reasonable for bone health, and sun-avoidance after melanoma makes deficiency more likely, which is why a vitamin D blood test is worth asking for.
- Studied dose
- If a 25-hydroxyvitamin D level is below 20 ng/mL (50 nmol/L), 1,000 to 2,000 IU vitamin D3 daily, rechecked after 3 months; there is no evidence for higher doses in melanoma.
- Cautions
- Doses above 4,000 IU daily without monitoring can cause high calcium. Do not use vitamin D as a reason to seek sun exposure or use a tanning bed; the melanoma risk of UV is far better established than any benefit from the vitamin D it produces.
What matters day to day
- Keep out of direct sun between 10 a.m. and 4 p.m. when the UV index is 3 or higher, and use shade and clothing as the first line: UPF 50 fabric blocks 98 percent of UV without needing reapplication, and a 3-inch brimmed hat and UV400 sunglasses cover the face, ears and eyelids where sunscreen is rarely applied properly.
- Apply a broad-spectrum SPF 30 or higher sunscreen to exposed skin at about 1 ounce (a shot glass) for the body and reapply every 2 hours and after swimming: most people apply a quarter to half the tested amount, which turns SPF 30 into SPF 5 to 10, and in the Nambour trial daily rather than occasional use halved new melanomas.
- Never use a tanning bed: the International Agency for Research on Cancer classifies UV-emitting devices as a group 1 carcinogen, first use before age 35 raises melanoma risk by about 75 percent, and there is no safe dose or so-called base tan.
- Do a full-body self-exam monthly with a mirror or partner and photograph your back, scalp and feet once a year: about half of melanomas are found by patients or partners, and a dated photo makes the question that matters, is this spot changing, answerable instead of a guess.
- Aim for at least 20 to 30 g of dietary fiber a day from vegetables, legumes, fruit and whole grains, and avoid starting probiotic supplements during immunotherapy without asking: in 128 patients on anti-PD-1 therapy, every 5 g of daily fiber was associated with a 30 percent lower risk of progression, while probiotic users had a lower response rate.
- Keep alcohol modest and do not smoke: each daily drink is associated with roughly a 10 to 20 percent higher melanoma risk in pooled cohorts, and smokers with melanoma have worse survival in registry data, so both are modifiable levers alongside sun behavior.
Prevention
- Apply broad-spectrum SPF 30+ sunscreen daily
- Avoid tanning beds and excessive sun exposure
- Wear protective clothing, hats, and UV-blocking sunglasses
- Perform monthly skin self-exams
- Get annual professional skin exams, especially with risk factors
When to See a Doctor
- Any new mole or skin lesion that changes in size, shape, or color
- A mole that bleeds, itches, or becomes painful
- A dark streak under a fingernail or toenail
- A sore that does not heal within a few weeks
Frequently Asked Questions
References
- Swetter SM, Tsao H, Bichakjian CK, et al.. Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology (2019)
- Wolchok JD, Chiarion-Sileni V, Rutkowski P, et al.. Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma. New England Journal of Medicine (2025)
- Blank CU, Lucas MW, Scolyer RA, et al.. Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma. New England Journal of Medicine (2024)
- Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. Journal of Clinical Oncology (2011)
- Chen AC, Martin AJ, Choy B, et al.. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. New England Journal of Medicine (2015)
- Hercberg S, Ezzedine K, Guinot C, et al.. Antioxidant supplementation increases the risk of skin cancers in women but not in men. Journal of Nutrition (2007)
- Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ (2012)
- Newton-Bishop JA, Beswick S, Randerson-Moor J, et al.. Serum 25-hydroxyvitamin D3 levels are associated with Breslow thickness at presentation and survival from melanoma. Journal of Clinical Oncology (2009)
- Spencer CN, McQuade JL, Gopalakrishnan V, et al.. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science (2021)
- National Cancer Institute. Melanoma Treatment (PDQ): Patient Version (2025)View source
Related Conditions
Lab tests that relate to melanoma
Have questions about Melanoma?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.